Johanna Mercier
Fortune : 18 M $ au 31/05/2026
Fortune : 18 M $ au 31/05/2026
Mme Johanna Mercier est directrice commerciale chez Gilead Sciences, Inc. Elle est membre du conseil d'administration de Neurocrine Biosciences, Inc. et du Leonard D Schaeffer Center For Health Policy & Economics, ainsi que du Robert Wood Johnson University Hospital, Inc. Mme Mercier était auparavant employée en tant que présidente commerciale américaine chez Bristol Myers Squibb Co. Elle a obtenu son diplôme de premier cycle à l'Université de Montréal et un MBA à l'Université Concordia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 124 234 ( 0,01% ) | 17 M $ | 31/05/2026 | |
| 27/05/2026 | 6 853 ( 0,01% ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2019 |
| NEUROCRINE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 15/04/2021 |
| ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 29/01/2024 |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Technology Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national